Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
2.
Australas J Dermatol ; 53(4): e69-72, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23157789

ABSTRACT

New onset or exacerbation of psoriasis vulgaris has been reported in a small number of patients after interferon (IFN)-α therapy. Herein, we report a case of generalized flare of pustular psoriasis induced by PEGylated IFN-α2b (PEG-IFN-α2b) in a 59-year-old woman with a 15-year history of pustular psoriasis and chronic hepatitis C. Interferon-α therapy was discontinued and the rash resolved after treatment with cyclosporin and systemic methylprednisolone. The potential side effect of PEG-IFN-α2b in inducing or exacerbating psoriasis should be kept in mind when treating patients with a history of psoriasis or pustular psoriasis.


Subject(s)
Antiviral Agents/adverse effects , Drug Eruptions/etiology , Hepatitis C, Chronic/drug therapy , Interferon-alpha/adverse effects , Polyethylene Glycols/adverse effects , Psoriasis/chemically induced , Disease Progression , Female , Humans , Interferon alpha-2 , Middle Aged , Recombinant Proteins/adverse effects
7.
Chin J Physiol ; 53(4): 199-207, 2010 Aug 31.
Article in English | MEDLINE | ID: mdl-21793329

ABSTRACT

Levocetirizine has been shown in observational studies in the west as an effective and satisfactory therapy for patients with allergic respiratory and skin disease. An open-label, multicentre observational study was conducted to investigate the patients' perception of levocetirizine in the treatment of allergic rhinitis (AR) and urticaria in Taiwanese patients. Three hundred and thirty-three patients (236 AR and 97 urticaria patients) attending out-patient clinics of medical centres across Taiwan were included in the study. Patients were treated with levocetirizine 5 mg once daily (AR patients for 2-4 weeks and urticaria patients for 2-6 weeks) and at the end of treatment, they evaluated for symptoms of disease, perception of change in symptoms, global efficacy and tolerability, global preference over previous antiallergic treatment, change in quality of sleep/daily activities, and safety and adverse events (AEs). Levocetirizine markedly improved the symptoms of AR and urticaria; with 70-75% of AR patients and 60-80% of urticaria patients reporting complete or marked improvements in individual symptoms. Asthma symptoms were completely or markedly improved in 44% of patients with AR and concomitant asthma. A majority of the patients was satisfied with levocetirizine therapy and 50-70% indicated preference for levocetirizine over previous therapy. Overall, 50-74% of all patients perceived improvements in quality of sleep/daily activities and 50-65% of the patients rated the onset of action for levocetirizine as very rapid or rapid. Somnolence was the most common AE, reported by 7.4% of AR and 7.0% of urticaria patients. The results of this study indicated that levocetirizine is an effective and satisfactory therapy for the management of allergic respiratory and skin disease in Taiwanese subjects.


Subject(s)
Cetirizine/therapeutic use , Histamine H1 Antagonists, Non-Sedating/therapeutic use , Rhinitis, Allergic, Perennial/drug therapy , Rhinitis, Allergic, Seasonal/drug therapy , Urticaria/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Cetirizine/adverse effects , Child , Female , Histamine H1 Antagonists, Non-Sedating/adverse effects , Humans , Male , Middle Aged , Patient Satisfaction , Sleep/drug effects , Taiwan , Young Adult
9.
Lung Cancer ; 63(1): 151-3, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18571759

ABSTRACT

A 46-year-old nonsmoking female was diagnosed with pulmonary lymphoepithelioma-like carcinoma (LELC). She simultaneously had a rare skin manifestation, erythema elevatum diutinum (EED), which did not respond to topical treatment. The patient underwent platinum-based chemotherapy and thoracic radiotherapy and had shown complete remission in both LELC and EED. EED is therefore considered as a paraneoplastic syndrome of pulmonary LELC in this case. Literature on LELC and EED were also reviewed.


Subject(s)
Carcinoma/diagnosis , Erythema/diagnosis , Lung Neoplasms/diagnosis , Paraneoplastic Syndromes/diagnosis , Antineoplastic Agents/pharmacology , Biopsy , Carcinoma/complications , Erythema/complications , Female , Humans , Lung/pathology , Lung Neoplasms/complications , Lung Neoplasms/pathology , Middle Aged , Platinum/pharmacology , Remission Induction , Skin/pathology , Tomography, X-Ray Computed/methods , Treatment Outcome
11.
Int J Dermatol ; 46(2): 206-9, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17269979

ABSTRACT

The vesicular variant of bullous pemphigoid is a clinical entity in which the principal type of lesions are multiple small tense vesicles in a symmetric distribution, instead of the classical large, more randomly distributed large bullae. We describe a 62-year-old female who developed a vesicular variant of bullous pemphigoid, with intensely pruritic vesiculopapular eruptions and erythematous irregularly outlined patches confluent on the face, neck, trunk, extremities and oral mucosa. Direct immunofluorescence revealed a linear deposition of IgG and C3 at the basement membrane zone of the skin, and indirect immunofluorescence detected circulating IgG autoantibodies reacting with antigens located on the epidermal side of skin split with 1 M NaCl. Indirect immunogold electron microscopy revealed IgG deposition at the underneath membrane of the basal cells and in the lamina lucida. In addition to the 230-kDa and 180-kDa bullous pemphigoid antigen, immunoblot analysis also demonstrated the presence of IgG antibodies reactive with 97-kDa and 45-kDa protein. Treatment with systemic corticosteroid, minocycline and antihistamines plus topical steroid resulted in moderate improvement. A few vesicles, however, continued to appear intermittently during the past year of treatment.


Subject(s)
Autoantibodies/blood , Autoantigens/immunology , Carrier Proteins/immunology , Cytoskeletal Proteins/immunology , Nerve Tissue Proteins/immunology , Non-Fibrillar Collagens/immunology , Pemphigoid, Bullous/immunology , Autoantigens/blood , Carrier Proteins/blood , Cytoskeletal Proteins/blood , DNA-Binding Proteins , Dystonin , Female , Fluorescent Antibody Technique , Humans , Immunoblotting , Microscopy, Electron , Middle Aged , Nerve Tissue Proteins/blood , Non-Fibrillar Collagens/blood , Pemphigoid, Bullous/blood , Pemphigoid, Bullous/pathology , Collagen Type XVII
13.
Eur J Dermatol ; 15(5): 396-400, 2005.
Article in English | MEDLINE | ID: mdl-16172052

ABSTRACT

Cutaneous mucinosis secondary to autoimmune collagen vascular disease is well recognized, but manifestation as cellulitis-like massive cutaneous mucinosis preceding dermatomyositis is unusual. Here we report a 21-year-old Taiwanese woman with a large, rapid onset, painful erythematous, edematous plaque, which histopathologically revealed septal panniculitis with fat necrosis and massive mucin deposition. Incapacitated muscle weakness of proximal extremities, generalized edema, heliotrope erythema, and Gottron's papules developed in a short period of time with high titers of serum muscle enzyme. Serological titers of ANA, anti-dsDNA, anti-ENA panels, and erythrocyte sedimentation rate, however, all showed unremarkable results. Diagnosis of dermatomyositis was confirmed by electromyographic findings of myopathy. As the disease progressed, large, deep cutaneous ulceration and vesiculobullous lesions also developed. In spite of aggressive treatment, the patient died 9 months after the disease onset, probably due to the complication of gastrointestinal ischemia and perforation.


Subject(s)
Dermatomyositis/complications , Intestinal Diseases/complications , Mucinoses/complications , Pyoderma Gangrenosum/complications , Skin Diseases, Vesiculobullous/complications , Vasculitis/complications , Adult , Dermatomyositis/pathology , Fatal Outcome , Female , Humans , Mucinoses/pathology , Muscle Weakness/complications , Pyoderma Gangrenosum/pathology , Skin Diseases, Vesiculobullous/pathology , Skin Ulcer/complications , Skin Ulcer/pathology
14.
Clin Cancer Res ; 11(16): 5769-77, 2005 Aug 15.
Article in English | MEDLINE | ID: mdl-16115915

ABSTRACT

PURPOSE: We investigated the role of candidate tumor suppressor and proapoptotic WOX1 (also named WWOX, FOR, or WWOXv1) in UVB-induced apoptosis and formation of cutaneous squamous cell carcinomas (SCC). EXPERIMENTAL DESIGN: Expression of WOX1 and family proteins (WWOX) in human primary cutaneous SCCs was examined by immunohistochemistry, in situ hybridization, and reverse transcription-PCR. UVB irradiation-induced WOX1 activation (Tyr33 phosphorylation and nuclear translocation), apoptosis, and cutaneous SCC formation were examined both in vitro and in vivo. RESULTS: Up-regulation of human WOX1, isoform WOX2, and Tyr33 phosphorylation occurred during normal keratinocyte differentiation before cornification and death. Interestingly, significant reduction of these proteins and Tyr33 phosphorylation was observed in nonmetastatic and metastatic cutaneous SCCs (P < 0.001), but without down-regulation of WWOX mRNA (P > 0.05 versus normal controls), indicating a translational blockade of WWOX mRNA to protein. During acute exposure of hairless mice to UVB, WOX1 was up-regulated and activated in epidermal cells in 24 hours. In parallel with the clinical findings in humans, chronic UVB-treated mice developed cutaneous SCCs in 3 months, with significant reduction of WOX1 and Tyr33 phosphorylation and, again, without down-regulation of WWOX mRNA. Human SCC-25 and HaCaT cells were transfected with small interfering RNA-targeting WOX1 and shown to resist UVB-induced WOX1 expression, activation, and apoptosis. CONCLUSIONS: WOX1 is essential for UVB-induced apoptosis and likely to be involved in the terminal differentiation of normal keratinocytes. During UVB-induced cutaneous SCC, epidermal cells have apparently prevented the apoptotic pressure from overexpressed WOX1 by shutting down the translation machinery for WWOX mRNA.


Subject(s)
Apoptosis/radiation effects , Carcinoma, Squamous Cell/genetics , Oxidoreductases/genetics , Protein Biosynthesis/genetics , Skin Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Animals , Carcinoma, Squamous Cell/etiology , Carcinoma, Squamous Cell/metabolism , Cell Differentiation/genetics , Cell Line, Tumor , Down-Regulation/genetics , Female , Gene Expression Regulation, Neoplastic/radiation effects , Humans , Immunohistochemistry , In Situ Hybridization , Keratinocytes/cytology , Keratinocytes/metabolism , Male , Mice , Middle Aged , Oxidoreductases/metabolism , Phosphorylation/radiation effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , Reverse Transcriptase Polymerase Chain Reaction , Skin Neoplasms/etiology , Skin Neoplasms/metabolism , Time Factors , Transfection , Tumor Suppressor Proteins , Tyrosine/metabolism , Ultraviolet Rays , WW Domain-Containing Oxidoreductase
15.
Leuk Lymphoma ; 45(7): 1375-84, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15359636

ABSTRACT

To assess the distribution of lymphomas in Taiwan according to the WHO (World Health Organization) classification, 175 recently diagnosed cases of malignant lymphomas were studied and the clinicopathologic data were analyzed. B-cell lymphomas accounted for 57.1% of cases, T-cell lymphomas 38.9%, and Hodgkin's lymphoma 4%. Extranodal lymphomas predominated (55.4%). The most common subtype of B-cell lymphoma was diffuse large B-cell lymphoma (33.1%). All tumor types believed to be derived from germinal center (GC) B-cells including follicular lymphoma (4.6%), Burkitt lymphoma (1.7%), Hodgkin lymphoma (4.0%), and GC-like diffuse large B-cell lymphoma (as defined by combined expression of bc1-6 and CD10) were rather uncommon as compared to frequencies seen in series from Western countries. The common T-cell lymphomas included nasal and extranasal NK/T cell lymphoma (7.4%), mycosis fungoides (7.4%), and unspecified peripheral T-cell lymphoma (6.9%). Adult T-cell leukemia/lymphoma was very uncommon and accounts for only 0.6%. The proportional increase in T-cell lymphomas that were unrelated to type I human T-cell lymphotropic virus (HTLV-1) may be linked to differential Epstein-Barr virus (EBV) oncogenesis. The survival data revealed that mantle cell lymphoma, NK/T-cell lymphoma, unspecified peripheral T-cell lymphoma, and subcutaneous panniculitis-like T-cell lymphoma had an aggressive course. Our results confirm the utility of the WHO classification scheme for prognostic stratification and further highlight the distinctive distribution pattern of malignant lymphoma in Taiwan including the higher relative incidence of T cell lymphomas and the rarity of germinal center-derived B-cell tumors.


Subject(s)
Lymphoma/epidemiology , Follow-Up Studies , Germinal Center/pathology , Humans , Immunophenotyping , Life Tables , Lymphoma/classification , Lymphoma/pathology , Lymphoma, B-Cell/epidemiology , Lymphoma, B-Cell/pathology , Prognosis , Survival Analysis , Taiwan/epidemiology , Terminology as Topic , World Health Organization
16.
Kaohsiung J Med Sci ; 20(5): 216-24, 2004 May.
Article in English | MEDLINE | ID: mdl-15233232

ABSTRACT

Cutaneous manifestations are common and often the presenting feature of human immunodeficiency virus (HIV) infection, but a comprehensive study of HIV-associated skin lesions is not available in Taiwan. We reviewed all skin lesions in all HIV patients diagnosed in our department between 1990 and 1998 to document the spectrum of skin manifestations, the frequency of each disorder, and their relationship with CD4 counts. A total of 64 HIV patients were studied, including 38 with acquired immunodeficiency syndrome (AIDS) (CD4 < 200 x 10(6) cells/L) and 26 who had not developed AIDS (non-AIDS). There were 142 episodes of skin conditions representing 25 different skin diseases, including oral candidiasis (15% in non-AIDS vs 71% in AIDS patients), drug eruptions, herpes simplex, seborrheic dermatitis, dermatophytosis, herpes zoster, secondary syphilis, condyloma acuminatum, Kaposi's sarcoma (16% among AIDS patients), hairy leukoplakia, and molluscum contagiosum (13% among AIDS patients), in decreasing order. Several unusual cases are briefly described, including verrucous herpes infection, condyloma-like molluscum contagiosum, and AIDS-associated pigmented erythroderma. In our study, 70% of all HIV patients had skin diseases, with an average of 2.2 conditions per patient (3.2 in AIDS patients vs 0.7 in non-AIDS patients; p < 0.001). A broad spectrum of HIV-associated skin diseases was observed in our series. The frequency of HIV-associated skin disease was 92% in AIDS patients and 39% in non-AIDS patients; 78% of skin lesions in AIDS patients were diagnosed when CD4 counts were below 100 x 10(6) cells/L.


Subject(s)
HIV Infections/complications , Skin Diseases/etiology , Adolescent , Adult , Aged , CD4 Lymphocyte Count , Female , HIV Infections/immunology , Humans , Male , Middle Aged , Sarcoma, Kaposi/etiology , Skin/pathology , Skin Diseases/pathology , Skin Neoplasms/etiology
17.
J Cutan Pathol ; 31(6): 458-61, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15186435

ABSTRACT

BACKGROUND: Pseudocarcinomatous hyperplasia (PCH) and marked tissue neutrophilia have been observed in cutaneous CD30(+) anaplastic large cell lymphoma (ALCL) occasionally and may cause misdiagnosis. METHODS: An unusual case of CD30(+) ALCL of the skin resembling keratoacanthoma (KA) both clinically and pathologically was described. Histologic examination and immunostaining were performed. RESULTS: A 55-year-old woman presented with a 3-month history of an enlarging hyperkeratotic tumor on the forehead with a central keratinous plug. Microscopic examination showed epithelial hyperplasia resembling KA and a diffuse background infiltrate of large atypical lymphoid cells in the dermis. The atypical cells resembled epithelial cells and were obscured by a massive infiltrate of eosinophils and neutrophils. Immunostaining confirmed the presence of a diffuse infiltrate of CD30(+) cells; these cells were negative for CD45RO, CD20, CD15, epithelial membrane antigen, anaplastic lymphoma kinase-1, and cytokeratin. There was no evidence of extracutaneous involvement. The findings were consistent with primary cutaneous CD30(+) ALCL of null cell phenotype with KA-like epithelial hyperplasia and marked eosinophilia and neutrophilia. CONCLUSIONS: Our case illustrates that primary cutaneous ALCL may be associated with KA-like PCH and concurrent marked tissue eosinophilia and neutrophilia. Diagnosis in such cases is challenging both clinically and histologically because the large atypical lymphoid cells may easily be obscured by the massive infiltrates of eosinophils and neutrophils or confused with invasive squamous cell carcinoma.


Subject(s)
Hyperplasia/pathology , Keratoacanthoma/pathology , Ki-1 Antigen/metabolism , Lymphoma, Large B-Cell, Diffuse/pathology , Skin Neoplasms/pathology , Carcinoma, Squamous Cell/pathology , Diagnosis, Differential , Eosinophilia/pathology , Epithelium/metabolism , Epithelium/pathology , Female , Forehead/pathology , Humans , Immunohistochemistry , Middle Aged , Neutrophils/pathology
18.
J Formos Med Assoc ; 103(1): 63-6, 2004 Jan.
Article in English | MEDLINE | ID: mdl-15026861

ABSTRACT

Follicular mucinosis (FM) is characterized histologically by mucinous degeneration of the outer root sheath of the hair follicle and sebaceous gland, accompanied by inflammatory infiltrate. It can occur as a primary idiopathic disorder or in association with benign or malignant diseases, most notably mycosis fungoides. In addition, it also can be found incidentally on histology. We describe an unusual case of follicular mucinosis in a 19-year-old man with acute lymphoblastic leukemia (ALL). One month after bone marrow transplantation, he developed cutaneous graft-versus-host disease (GVHD) involving the palms and soles, which was followed 12 days later by the appearance of multiple erythematous follicular papules and plaques on his face, auricles, and postauricular area. Biopsy of follicular plaque revealed changes of follicular mucinosis without evidence of graft-versus-host disease or leukemia cutis. The follicular rash was associated with prominent peripheral eosinophilia. The rash and eosinophilia resolved after 2 and 4 weeks, respectively. In conclusion, we report a case of FM occurring as a transient reaction during the course of cutaneous GVHD following bone marrow transplantation for ALL. Awareness of this condition may avoid undue concern that the rash might represent a manifestation of GVHD, cutaneous relapse of the hematological malignancy, or a drug allergy.


Subject(s)
Bone Marrow Transplantation/adverse effects , Mucinosis, Follicular/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Adult , Graft vs Host Disease/etiology , Humans , Male
19.
J Dermatol ; 31(9): 727-30, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15628318

ABSTRACT

Eosinophilic pustular folliculitis (EPF) (Ofuji's disease) is a rare dermatosis of unknown etiology. We describe a 45-year-old Chinese woman who developed EPF on her face seven years after having nose and chin augmentation with subcutaneous silicone injections.


Subject(s)
Facial Dermatoses/diagnosis , Folliculitis/diagnosis , Silicones/adverse effects , Chin , Diagnosis, Differential , Facial Dermatoses/chemically induced , Facial Dermatoses/pathology , Female , Folliculitis/chemically induced , Folliculitis/pathology , Humans , Middle Aged , Nose , Surgery, Plastic/adverse effects
20.
J Formos Med Assoc ; 102(9): 656-60, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14625614

ABSTRACT

The neutral lipids existing in the intercellular spaces of the stratum corneum (SC) provide a permeability barrier to prevent water loss. Nile red is the most sensitive lipid stain for tissue sections. However, due to the extremely flattened morphology of corneocytes and the resolution limits of the light microscope, Nile red staining is seldom used as a fluorescent probe for the lipid-rich SC. In this study, we modified the traditional method for visualization of intracellular lipid by adding 4% potassium hydroxide after Nile red staining. This modified method not only allowed visualization of lipids existing in the intercellular membrane regions and the lateral junctions of the adjoining corneocytes, but also clearly demonstrated small lipid droplets within pathological corneocytes. These features were not observed with the traditional staining method. Thus, this modified Nile red staining method greatly improved the resolution of the SC lipids under light microscopy and should be useful for studying lipid depositions in both normal and pathological SC.


Subject(s)
Epidermal Cells , Fluorescent Dyes , Lipids/analysis , Oxazines , Staining and Labeling/methods , Adolescent , Adult , Aged , Aged, 80 and over , Epidermis/chemistry , Female , Humans , Hydroxides , Male , Middle Aged , Potassium Compounds
SELECTION OF CITATIONS
SEARCH DETAIL
...